Aryl Hydrocarbon Receptor Agonists in Atopic Dermatitis
It’s an exciting era for topicals in atopic dermatitis with several non-steroidal treatment options, including aryl hydrocarbon receptor agonists. In an interview with Next Steps in Derm, in partnership with Skin of Color Update and with support from Organon, Mona Shahriari, MD, FAAD, shares how tapinarof, an aryl hydrocarbon receptor agonist, addresses the two pillars of atopic dermatitis mana …
It’s an exciting era for topicals in atopic dermatitis with several non-steroidal treatment options, including aryl hydrocarbon receptor agonists. In an interview with Next Steps in Derm, in partnership with Skin of Color Update and with support from Organon, Mona Shahriari, MD, FAAD, shares how tapinarof, an aryl hydrocarbon receptor agonist, addresses the two pillars of atopic dermatitis mana … Continue reading "Aryl Hydrocarbon Receptor Agonists in Atopic Dermatitis"
Scarring alopecias in skin of color are increasingly recognized and remain a major cause of irreversible hair loss. During the 2025 Skin of Color Update in New York City, Susan C. Taylor, MD, presented an updated clinical approach to identifying and managing lichen planopilaris (LPP), frontal fibrosing alopecia (FFA), and central centrifugal cicatricial alopecia (CCCA) with a focus on early detect …
Periorbital hyperpigmentation is common in patients with skin of color, though understanding the condition – and selecting an effective treatment – can be a challenge. Darkening around the eyes can appear as brown, blue-grey, blue, violet, or purple -- all signs of the root causes -- which include extra deposits of melanin, inflammation, prominent veins, and structural changes. Periorbital hyp …
When treating pediatric patients, knowing how to appropriately use topical steroids in this patient population is essential, according to Dr. Karan Lal, a dermatologist in Scottsdale, Ariz. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Lal, who shares how to taper topical steroids and the role of non-steroidal agents. Hear the latest in the safety profile of topica …
Bullous diseases, including bullous pemphigoid, may present differently in patients with darker skin tones. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Prince Adotama, assistant professor at NYU Langone’s Ronald O. Perelman Department of Dermatology. Watch as Dr. Adotama outlines what clinicians need to know about bullous pemphigoid. Learn how the treatment lan …